IntelliPharmaCeutics International Inc IPCIQ
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- — / —
- Shares Outstanding
- 33.09M
- Market Cap
- $33.09
- Volume/Avg
- 13,500 / 34,219
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
IntelliPharmaCeutics International Inc is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The company's patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a wide range of existing and new pharmaceuticals. It has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development. The company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 11
Valuation
Metric | IPCIQ |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | IPCIQ |
|---|---|
Quick Ratio | 0.05 |
Current Ratio | 0.06 |
Interest Coverage | −8.88 |
Quick Ratio
IPCIQ
Profitability
Metric | IPCIQ |
|---|---|
Return on Assets (Normalized) | −120.18% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
IPCIQ
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|RS%RH&# | LOCK|s!D# | $139B | |||
| Moderna Inc MRNA | LOCK|%#@&n# | LOCK|c> | $103B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|<HV>v$ | LOCK|S&R%# | $94B | |||
| argenx SE ADR ARGX | LOCK|<rxWJf# | LOCK|ln | $58B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|Px&$%& | LOCK|q> | $47B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|%b^&n%Z | LOCK|><V! | $30B | |||
| Incyte Corp INCY | LOCK|%r>nHp | LOCK|HX | $24B | |||
| BioNTech SE ADR BNTX | LOCK|??&%kGk | LOCK|#DD | $22B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|&#vm!?z | LOCK|#yBMh | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|>rPl$MN | LOCK|@VQ | $15B |
United States